Older Adults with Mild Cognitive Impairment Can Reliably Express Their Preferences for Health Care Using Discrete Choice Experiments

Published Jul 3, 2014
Adelaide, South Australia – Researchers from Flinders University found that mild cognitive impairment did not affect the ability of older adults to reliably respond to questions about their preferred rehabilitation services following hip fracture. Older adults (aged 65 years and over) represent an increasing proportion of the population with rising expectations for quality health and aged care services targeted to meet their needs and preferences. A recent study, “Cognitive Overload? An Exploration of the Potential Impact of Cognitive Functioning in Discrete Choice Experiments with Older People in Health Care,” published in Value in Health, was among the first to use discrete choice experiments (DCE), a popular method for quantifying preferences, to focus on older people, especially those with cognitive impairment. Through the use of a questionnaire completed by 74 older adults in the acute phase following a hip fracture to determine whether cognition influenced their ability to reliably complete a DCE, the researchers found that in comparison with those with good cognitive functioning, mild cognitive impairment did not influence the ability of older adults to respond reliably. Study co-author Professor Julie Ratcliffe, PhD, from Flinders University says, “This study demonstrates the ability of older adults, including those with mild cognitive impairment, to make reliable choices in relation to the characteristics of care of importance to them, and demonstrates the potential for the wider utilization of DCE methods to elicit treatment and service preferences across health and aged care sectors.”

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information: www.ispor.org

Related Stories

International Study Confirms Universally Applicable Framework for Defining Digital Health Interventions

Jan 21, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a comprehensive international study demonstrating that the PICOTS-ComTeC framework serves as an effective universal standard for defining patient-facing digital health interventions. The report, “Towards a Common Ground for Defining Digital Health Interventions, Mapping Digital Health Frameworks to PICOTS-ComTeC: An ISPOR Special Interest Group Report” was published in the January 2026 issue of Value in Health.

New Research Collection Reveals How Artificial Intelligence Is Reshaping Health Economics

Nov 6, 2025

The PhRMA Foundation and ISPOR announced the publication of a special themed section of research papers that explores the dynamic intersection of artificial intelligence (AI) and health economics and outcomes research (HEOR).

ISPOR Announces 2025 Health Economics and Outcomes Research Award Honorees

Oct 20, 2025

ISPOR announced the recipients of its 2025 Health Economics and Outcomes Research (HEOR) Scientific and Leadership Awards. ISPOR Scientific Awards are designed to foster and recognize excellence and outstanding achievement in HEOR and its Leadership Awards recognize excellence and outstanding leadership in the field.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×